Personalised Phage Therapy, From Evidence to Implementation in Estonia

Antimicrobial resistance represents a growing clinical challenge in Estonia and globally. Personalised phage therapy offers a promising approach for treating complex bacterial infections where conventional therapies fail. This conference convenes clinicians, scientists, and regulators to discuss the current state of phage therapy and its evidence-based implementation in Estonia.

09:30-10:00 Registration and Coffee

10:00-10:15 Opening Remarks (Prof Joel Starkopf, MD, PhD and Prof Tanel Tenson PhD)

10:15-10:40 New Antibiotics and Bacteriophages: Do We Need Both? (PhD Prof Irja Lutsar, MD, PhD)

10:40-11:30 Personalised Phage Therapy with an Emphasis on the Belgian Magistral Framework (Prof Jean-Paul Pirnay, PhD)

11:30-11:50 Coffee Break

Session 1: Clinical Fundamentals

11:50-12:20 Phage Therapy in Italy: Clinical Applications and Regulatory Challenges ( Dr Novella Cesta, MD, PhD)

12:20-12:50 Phage Therapy in Latvia: Clinical Experience and Future Perspectives (Dr Kārlis Rācenis, MD, PhD)

12:50-13:20 Phage Therapy in Orthopedic Infections: Clinical Perspectives ( Dr Kaspar Tootsi, MD, PhD)

13:20-14:30 Lunch

Session 2: Regulation and Implementation

14:30-15:00 Regulatory and Quality Aspects of Phage Therapy (Helerin Eiche, PhD)

15:00-15:30 Building Phage Collections for Rapid Access (Karin Ernits, PhD )

15:30-16:20 Panel discussion: Translating Phage Therapy into Clinical Practice in Estonia

16:20-16:30 Closing Remarks (Prof Tanel Tenson, PhD)

17:00-19:30 Networking Dinner (optional)

Practical Information